ArticleJACC. Advances2026
Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlcohol septal ablation (ASA) may necessitate a repeat procedure if the obstructive myocardium is not sufficiently ablated; however, the outcomes after repeat ASA are not well studied.
objectivesThe objective of the study was to evaluate outcomes in patients with obstructive hypertrophic cardiomyopathy after repeat ASA.
methodsOf the 663 patients with obstructive hypertrophic cardiomyopathy who underwent ASA, 84 with repeat ASA were analyzed. Residual left ventricular (LV) obstruction was stratified according to proximal or distal obstruction. The primary outcome was the absence of symptomatic residual LV obstruction, defined as NYHA functional class I or LV gradient <50 mm Hg, or both at 12 months after repeat ASA. Factors associated with the primary outcome were assessed using logistic regression. Secondary outcomes included cardiovascular mortality, fatal arrhythmia, heart failure hospitalization, and 3rd intervention.
resultsOf the 84 patients, 41 had proximal and 43 had distal obstruction. Five patients failed to achieve technical success. One patient with proximal obstruction died due to infection during the index hospitalization. At 12 months after repeat ASA, 80.7% (67/83) achieved the primary endpoint: 90.0% (36/40) with proximal obstruction and 72.1% (31/43) with distal obstruction. The primary outcome was associated with proximal obstruction (adjusted OR: 4.06; 95% CI: 1.09-18.3). During a median follow-up of 7.1 years, there were 13 deaths (15.5%). Cardiovascular mortality and heart failure hospitalization were similar between those with proximal or distal obstruction, whereas fatal arrhythmia and 3rd interventions were more frequent in distal obstruction.
conclusionsThe site of residual obstruction may be important for understanding long-term outcomes after repeat ASA, but this requires further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.